The discovery of a selective CDK4/6 inhibitor for the treatment of cancer: the journey from bench to bedside
January 23, 2020
10:30 AM - 11:30 AM
Location
College of Pharmacy, Room 134-1
Address
833 S. Wood Street, Chicago, IL 60612
Calendar
Download iCal FileClick here for more information
UICentre & Center for Clinical and Translational Science
Dr. Larry Gelbert, LMG PharmaTech LLC
Dr. Gelbert will be sharing his perspective on the discovery and characterization of Abemaciclib (LY2835219), the Lilly CDK4/6 inhibitor. Dr. Gelbert was the lead biologist during the pre-clinical phase of this project at Eli Lilly and Company
Date posted
Jan 16, 2020
Date updated
Jan 16, 2020